Background
==========

Hearing loss, acquired or genetic, is a major worldwide public health concern. Numerous genes have been linked to hearing disorders \[[@B1]\]. These disorders may be syndromic or nonsyndromic; conductive, sensorineural, or mixed; and prelingual or postlingual \[[@B2]\]. The various genetic forms of hearing loss are distinguished based on otologic, audiologic and physical examination combined with linkage analysis. Some representative deafness genes that have been identified include the Alport syndrome (*COL4A3, COL4A4 or COL4A5 genes*), branchio-oto-renal syndrome (*EYA1*gene), Mohr-Tranebjaerg syndrome (*TIMM8A*gene), Pendred syndrome (*SLC26A4*gene), Jervell and Lange-Nielsen Syndrome (*KVLQT1 and KCNE1 genes*), Usher syndrome with its several types, Norrie disease (*NDP gene*), DFNB1 (*GJB2*gene), DFN3 (*POU3F4*gene), DFNB4 (*SLC26A4*gene), DFNA6/14 (*WFS1*gene), and several others \[[@B3],[@B4]\]. The mutational analysis of genes such as *GJB2*(encoding the protein connexin 26) and *GJB6*(encoding the protein connexin 30) \[[@B3],[@B5],[@B6]\] has aided diagnosis and geneticcounselling.

Syndromic hearing loss is associated with a variety of other clinical findings and is relatively less prevalent. In contrast, nonsyndromic hearing loss accounts for more than 70% of deafness cases and involves autosomal as well as X or Y -linked deafness phenotypes \[[@B7]\]. The molecular causes of nearly all nonsyndromic hearing loss are associated with inner ear structural damage, and changes in both the inner and the middle ear \[[@B8]\]. Mutations in genes such as the *ACTG1*, *COCH*, *COL11A2*, *DFNA5*, *EYA4*, *GJB2*, *GJB6*, *KCNQ4*, *MYO6*, *MYO7A*, *TECTA*, *TMC1*, and *WFS1*, as well as altered expression of genes such as *GJB3*and *MYO1A*have been associated with the autosomal dominant types that are generally progressive and involve changes in inner ear \[[@B9]-[@B11]\]. The autosomal recessive phenotypes are associated with mutations in genes such as the *CDH23*, *CLDN14*, *ESPN*, *GJB2*, *GJB6*, *MYO15A*, *MYO6*, *MYO7A*, *OTOF*, *PCDH15*, *SLC26A4*, *STRC*, *TECTA*, *TMC1*, *TMIE*, *TMPRSS3*, and *USH1C*, as well as altered expression of *GJB3*\[[@B8]\].

The map locations of a large number of nonsyndromic autosomal recessive deafness phenotypes are known, but the specific genes responsible for all these phenotypes have not been identified \[[@B4]\]. The cloning of genes involved in such phenotypes requires refinement of the suspected genomic interval to as short a region as possible by linkage analysis. However, it is not always possible to map a gene within an interval that is amenable for mutation analysis. The mutation analysis of all genes encoded by a large genomic interval is extremely labor-intensive. We describe here a bioinformatic approach that can reduce the candidate genes to a manageable number for mutation analysis. Initially, all the genes from a particular locus are cross-referenced to the databases of expressed mouse inner ear genes and the expressed human cochlear genes. The alternative procedure included a search for interacting proteins for the gene products mapping to the candidate region. As presented here, this approach has led to a set of specific candidate genes.

Results and discussion
======================

The locations of 23 autosomal dominant and 27 autosomal recessive nonsyndromic deafness phenotypes mapped to several chromosomes downloaded from hereditary hearing loss homepage are shown in Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}\[[@B4]\]. Additional loci for nonsyndromic conditions are mapped to chromosomes 1, 8, X and Y \[[@B4]\]. The hereditary hearing loss homepage is updated on a regular basis. The marker boundaries of these locations encompass between 1.4 and 18.6 million basepairs (Mbp) for various loci. To generate a set of candidate genes for the listed loci, a strategy schematically represented in Figure [1](#F1){ref-type="fig"} was followed. The determination of coding sequences and/or genes in a genomic region was made by Unigene \[[@B12]\]. However, the genes encoded in a large genomic interval are too many to be characterized by mutational analysis in a gene-by-gene approach. Therefore, we used the human cochlea and mouse inner ear expression databases \[[@B13],[@B14]\] to eliminate from the candidate list certain genes that were not expressed in these organs. Such *in silico*expression analysis relies on the assumption that the expression databases are comprehensive. However, the characterization of all transcripts expressed in the ear is far from complete. We, therefore, introduced another step in our candidate gene strategy by taking advantage of the human protein reference database (HPRD) and generated a list of interacting genes for every gene mapping to candidate deafness loci \[[@B15]\]. The rationale for protein interaction is as follows. If a gene encoded in the candidate region interacts with a gene that is either involved in inner ear development/function, or a protein shows interaction with more than one candidate genes mapping to different loci, then such a gene is likely to be involved in the phenotype in question. The interaction pattern of the gene products from Usher syndrome is a good example to illustrate this point. The known gene products for several Usher syndrome loci are known to form interactions *in vivo*\[[@B16]\]. The mutation of each one of these genes affects protein interactions and influences Usher type 1 phenotype \[[@B17]\]. The five forms of Usher syndrome have defects in myosin VIIA, harmonin, cadherin 23, protocadherin 15, and a putative scaffolding protein sans. Harmonin binds sans, and it also binds myosin VIIA and protocadherin 15 \[[@B34]\]. The role of cadherins in mediating cell-cell interaction is well-characterized. Furthermore, interactions of harmonin (*USH1C*) with *USH2A*, *USH2C*and *USH2B*are mediated by PDZ domains \[[@B35],[@B36]\]. In retrospect, if the interacting protein strategy had been used to select candidate genes for Usher syndrome subtypes, it is likely that several genes could have been eliminated from consideration. Therefore, it is reasonable to assume that physical interactions will exist between proteins that are involved in inner ear developmental pathway or inner ear signal transduction pathways, and mutations in any one protein of the pathway is likely to give the same altered phenotype. If proteins of interacting networks can be identified or predicted, then such genes are natural candidates for a given phenotype. The above hypothesis is the underlying rationale for incorporating interacting proteins as a criterion for selecting candidate genes presented in this paper. Briefly, the strategy is as follows. First, assemble the genes encoded in all candidate intervals, list the proteins that interact with genes in the candidate region, and then search for candidates on different loci that interact with a common protein. Such a criterion will fulfil the rationale of putative involvement of proteins at two different loci involved in a common biological process, and by association the respective genes mapping to two different loci will be considered as candidates.

The application of candidate gene isolation is demonstrated for the autosomal dominant condition DFNA27. The gene is mapped to the genomic interval 4q12 spanning 15 Mbp \[[@B4]\]. This region codes for 36 known and 30 hypothetical proteins (Table [3](#T3){ref-type="table"}) \[[@B18]\]. The comparison of these genes to expression databases reduced the list to 10 genes from the human cochlear database and three found in the mouse inner ear (Table [4](#T4){ref-type="table"}) \[[@B13],[@B14],[@B19]\]. The possibility remained for the elimination of a stronger candidate just on the basis that it did not score a hit in expression databases. To avoid such an error, we have assembled lists of interacting proteins by using the human protein reference database (HPRD) \[[@B15]\] for every gene identified by GeneRetriever^®^from the candidate region. If an interactor of a gene in the candidate interval is expressed in inner ear then the gene is considered a candidate. Alternatively, the interacting genes from a specific locus list were compared against lists from other loci to identify if a hit was scored against proteins among two or more lists. The original genes corresponding to such interactor(s) were considered as candidates for the respective deafness loci. The strong candidates, based on the above analyses, for various deafness loci are presented in Table [5](#T5){ref-type="table"}.

In principle, the interactions-based strategy can be targeted to identify candidates for deafness if a database for interacting proteins involved in inner ear development and function is available. For example, oncomodulin and prestin are expressed in outer hair cells \[[@B20]\]. The protein interaction approach could link the possible candidate genes to specific cochlear cells by identifying known interactants. If the interactors happen to map to a region harboring a deafness gene, such interactors are obvious candidates for mutational analysis. However, such an approach will require identification of interacting proteins. The primary limitation of the *in silico*approach described here is inadequate description of interacting protein networks.

The strong candidate list includes genes such as various cadherins, collagens, some cytoskeletal components and a number of growth factors and inner ear specific transcripts. For example, HAT (Human airway trypsin-like protease) from the DFNA27 locus is known to enhance cell growth and IL-8 production. It has been implicated in induction of PAR-2 (protease activated receptor)-mediated IL-8 release in psoriasis vulgaris \[[@B21]\]. Because HAT is expressed in the ear, and protease activated receptor (PAR-2) has the ability to activate G-proteins followed by an increase in calcium ion concentration, we consider HAT as a candidate. KDR(kinase insert domain receptor), a vascular endothelial growth factor(VEGF) receptor-type 2, from the same locus shows age-dependent expression in the inner ear \[[@B22]\]. Our analyses indicated that only a fraction (200/2400) of genes mapping to various genomic intervals was expressed in the inner ear. We attribute these observations to depth of inner ear libraries. It is likely that the genes being scored in these libraries have multiplicity for certain transcripts and absence of other transcripts. For example, out of 153 genes at the DFNA7 locus, only 18 genes are present in the cochlear library. We cannot reasonably rule out the expression of the remaining 135 genes in the inner ear. Therefore, the approach presented here will be more comprehensive if we do not include ear expression in this scheme. Consequently, in a second attempt to mine the protein-interaction data obtained from the HRPD, we analyzed all genes encoded in the candidate intervals for their interactors. The interaction data were considerably exhaustive and resulted in many more possible candidates with their expression not reported in the ear expression library. A summary of gene numbers at different loci before and after interacting proteins analysis using the ear-expression scheme is presented in Table [6](#T6){ref-type="table"}. The mouse syntenic genes are also indicated in these results. The number of unfiltered candidate genes for each locus obtained by interacting proteins analysis is shown in Table [7](#T7){ref-type="table"}. To elucidate the relevance of genes not found in the ear-expression library as possible candidates, we performed a literature search cross-referencing the identified gene with any reported hearing-associated condition in humans or other model animals. Some of these genes were linked to ear-development or hearing impairment as a secondary or unrelated symptom of other conditions. For example, Neurod1 gene mapping to DFNB27 locus was not reported in any of the inner ear libraries. However, it appears to participate in the development of the auditory system as NeuroD1 null mice exhibited severe reduction of sensory neurons in the cochlear-vestibular ganglion \[[@B23]\]. E2F3, a transcription factor of the E2F family mapping to the DFNA21 locus, may be indirectly implicated by its ability to regulate cell proliferation possibly during the developmental stages \[[@B24]\]. Other candidate genes from the unfiltered candidate analysis for the various loci are listed in Table [8](#T8){ref-type="table"}. Thus the unfiltered strategy adds 51 candidates for 25 loci and expands the candidate list to 92 genes for further mutation analysis.

Our approach indicated the presence of possible candidates within most of the mapped loci. However, prediction of candidate genes was not easy for loci indicated by asterisks in Table [7](#T7){ref-type="table"}, because the genes mapping to these loci did not fulfil the criteria we have employed. We further examined these genes on the basis of their reported function. The following description pertains to specific genes that are not indicated in the candidate lists. Within the DFNA16 locus, SCNA3 and SCNA2, both being voltage-gated sodium channels, can be considered candidates based on involvement of related sodium channels in hearing \[[@B25]\]. Similarly, ATP2C1 in DFNA18 locus is a likely candidate because mutations in a related ATPase have been shown in mice that are profoundly deaf and have a balance defect \[[@B26]\]. The EphB1 gene, within the DFNA18 locus, plays a major role during the development of the inner ear in mice \[[@B27]\]. The DFNA23 locus has six1 gene that plays a pivotal role in the control of the mouse otic vesicle patterning \[[@B28]\]. Neugrin, mapping to DFNA30 locus, appeared to be an appropriate candidate as it was shown to be up-regulated throughout neuronal differentiation \[[@B29]\]. A possible candidate for the DFNA47 locus is the transcription factor Nfib, an essential player in the maturation of lungs and brain development \[[@B30]\]. The splicing regulation carried out by Pnn, mapping to the DFNB5 region, is a reasonable candidate \[[@B31]\]. We believe the genes presented in this article may serve as starting candidates toward identifying molecular mechanisms for specific deafness phenotypes.

Conclusion
==========

We have used an *in silico*strategy to assemble a list of candidate genes that are positionally linked to and could be causing specific nonsyndromic hereditary hearing loss conditions. As presented here, a list of 2378 genes mapping to various genomic intervals have been narrowed down to 92 genes as candidates. These candidates may be analyzed for mutations in various deafness phenotypes in parallel with attempts to further narrow down the suspected region by genetic linkage analysis. It warrants mention that the potential of the approach presented here will be better harnessed as more information becomes available about inner ear transcripts and protein interaction networks.

Methods
=======

Generating list of loci for *in silico*prediction
-------------------------------------------------

The list of most current information and identified loci for the various nonsyndromic hearing loss and syndromic forms was obtained from the Hereditary Hearing Loss Homepage and the survey of latest literature \[[@B4]\]. The list of deafness loci with unknown specific genes for the autosomal dominant, autosomal recessive, and syndromic forms was also compiled from the same web based source.

GeneRetriever for EST identification within each deafness locus
---------------------------------------------------------------

A list of all cloned and identified genes from within each of the listed genomic intervals was obtained using GeneRetriever^®^, a Perl-based data mining software that has a simple graphical user interfaces \[[@B12]\]. It automatically retrieves from either NCBI or Ensembl databases information that includes all genes and transcripts located in a genomic interval flanked by two genetic markers.

Database analysis
-----------------

The list of genes and transcripts for each specific locus obtained using GeneRetriever^®^was compared against two sets of ear gene-expression databases. The first set includes genes expressed in the developing ear \[[@B13]\]. This list is a compilation of the numerous genes that are expressed at different stages during inner ear development in two animal species. The second set was obtained from fetal cochlear cDNA library and EST database (updated as of 2002) of the Morton Hearing Research Group \[[@B14]\]. The data present in this set was adapted from Unigene \[[@B12]\]. The database has 14,805 ESTs, and 12,624 ESTs are sorted by Unigene into 4,519 independent clusters. Unigene did not classify the remaining ESTs due to factors such as possible contaminating sequences, very small inserts, or excessive repetitive elements. For a gene within a particular locus to be considered for candidacy, it has to be present in either of the above two databases. Genes that were not present in either expression databases were initially eliminated from consideration. It warrants mention that functional significance of expressed sequences in human and mouse inner ear has been used to propose deafness candidates \[[@B32],[@B33]\].

Human reference protein database
--------------------------------

In comparing the two sets of databases to the list of genes and transcripts within each hereditary hearing loss locus obtained using GeneRetriever^®^, we were able to compile a list of possible candidate genes for the various loci. To further narrow-down and refine this list, we obtained a list of all known interacting genes for each of the known and candidate genes using the Human Reference Protein Database (HRPD)\[[@B15]\]. The interacting proteins for all the genes within the mapped loci were obtained regardless of whether the gene is present in the two data sets of inner-ear expressed transcripts. In our first attempt of mining the data, if a gene is not present in the data set but its interacting proteins are expressed or present in the cochlea or identified in the table of gene expression in the developing ear, then this gene is considered a candidate. In our second attempt, we removed the ear-expression filter requirement. Therefore, any interacting and repeating protein was given consideration. Identifying candidate interacting genes that repeat in many loci supported their candidacy, resulting in a more comprehensive candidate list.
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###### 

Autosomal dominant nonsyndromic loci.

  Locus Name   Location
  ------------ -------------
  DFNA7        1q21--q23
  DFNA16       2q24
  DFNA18       3q22
  DFNA21       6p21
  DFNA23       14q21--q22
  DFNA24       4q
  DFNA25       12q21--24
  DFNA27       4q12
  DFNA30       15q25--26
  DFNA31       6p21.3
  DFNA32       11p15
  DFNA34       1q44
  DFNA37       1p21
  DFNA41       12q24--qter
  DFNA42       5q31.1--32
  DFNA43       2p12
  DFNA44       3q28--29
  DFNA47       9p21--22
  DFNA49       1q21--q23
  DFNA50       7q32
  DFNA53       14q11--q12
  DFNA54       5q31

###### 

Autosomal recessive nonsyndromic loci.

  Locus Name   Location
  ------------ ------------------
  DFNB5        14q12
  DFNB13       7q34--36
  DFNB14       7q31
  DFNB15       3q21--q25, 19p13
  DFNB17       7q31
  DFNB19       18p11
  DFNB20       11q25--qter
  DFNB24       11q23
  DFNB25       4p15.3--q12
  DFNB26       4q31
  DFNB27       2q23--q31
  DFNB28       22q13
  DFNB32       1p13.3--22.1
  DFNB33       9q34.3
  DFNB35       14q24.1--24.3
  DFNB38       6q26--q27
  DFNB39       7q11.22--q21.12
  DFNB40       22q
  DFNB42       3q13.31--q22.3
  DFNB44       7p14.1--q11.22
  DFNB46       18p11.32--p11.31
  DFNB48       15q23--q25.1
  DFNB49       5q12.3--q14.1.
  DFNB55       4q12--q13.2
  DFNB58       2q14.1--q21.2
  DFNB60       5q22--q31

###### 

GeneRetriever list of known genes found within the DFNA27 locus.

  Gene ID    Gene Entrez   Type    GeneDescription                                                           Expressed in Cochlear Library   Interactor Cochlear Protein
  ---------- ------------- ------- ------------------------------------------------------------------------- ------------------------------- -----------------------------
  KDR        3791          Known   kinase insert domain receptor (a type III receptor tyrosine kinase)       Yes                             VEGF A, Grb2, CDH5
  FLJ13352   79644         Known   hypothetical protein FLJ13352                                             No                              
  TPARL      55858         Known   TPA regulated locus                                                       Yes                             
  CLOCK      9575          Known   clock homolog (mouse)                                                     No                              
  PDCL2      132954        Known   phosducin-like 2                                                          No                              
  NMU        10874         Known   neuromedin U                                                              Yes                             
  SEC3L1     55763         Known   SEC3-like 1 (S. cerevisiae)                                               No                              
  KIAA0635   9662          Known   KIAA0635                                                                  Yes                             
  KIAA1211   57482         Known   KIAA1211 protein                                                          No                              
  MRPL22P1   359738        Known   mitochondrial ribosomal protein L22 pseudogene 1                          No                              
  NRPS998    132949        Known   2-aminoadipic 6-semialdehyde dehydrogenase                                No                              
  PPAT       5471          Known   phosphoribosyl pyrophosphate amidotransferase                             Yes                             
  PAICS      10606         Known   phosphoribosylaminoimidazole carboxylase, succinocarboxamide synthetase   No                              
  SRP72      6731          Known   signal recognition particle 72kDa                                         No\*                            Caspase 3
  ARL9       132946        Known   ADP-ribosylation factor-like 9                                            No                              
  GLDCP      2732          Known   glycine dehydrogenase (decarboxylase) pseudogene                          No                              
  HOP        84525         Known   homeodomain-only protein                                                  Yes                             HDAC2
  SPINK2     6691          Known   serine protease inhibitor, Kazal type 2 (acrosin-trypsin inhibitor)       No                              
  REST       5978          Known   RE1-silencing transcription factor                                        Yes                             
  C4orf14    84273         Known   chromosome 4 open reading frame 14                                        No                              
  POLR2B     5431          Known   polymerase (RNA) II (DNA directed) polypeptide B, 140kDa                  Yes                             
  IGFBP7     3490          Known   insulin-like growth factor binding protein 7                              No\*                            VEGF A, IGF1
  SRIL       6644          Known   sorcin-like                                                               No                              
  LPHN3      23284         Known   latrophilin 3                                                             No                              
  EPHA5      2044          Known   EphA5                                                                     No                              
  CENPC1     1060          Known   centromere protein C 1                                                    No                              
  BRDG1      26228         Known   BCR downstream signaling 1                                                No\*                            KIT
  FLJ10808   55236         Known   hypothetical protein FLJ10808                                             Yes                             
  GNRHR      2798          Known   gonadotropin-releasing hormone receptor                                   No                              
  HAT        9407          Known   airway trypsin-like protease                                              Yes                             PAR-2
  FLJ16046   389208        Known   FLJ16046 protein                                                          No                              
  YT521      91746         Known   splicing factor YT521-B                                                   No\*                            KHDRBS3, FYN
  DESC1      28983         Known   DESC1 protein                                                             No                              
  UGT2B17    7367          Known   UDP glycosyltransferase 2 family, polypeptide B17                         No                              

\*These genes are not listed in the human cochlear database. However, their interactors are present in the cochlear database.

###### 

Cochlear-expressed EST found within DFNA27 locus.

  Locus    Location   Genes from Cochlea   Genes from Mouse   Genes from Known Disorders
  -------- ---------- -------------------- ------------------ ----------------------------
  DFNA27   4q12       FLJ10808             EPHA5              None
                      HAT                  HAT                
                      HOP                  KDR                
                      KIAA0635                                
                      KDR                                     
                      NMU                                     
                      POLR2B                                  
                      PPAT                                    
                      REST                                    
                      TPARL                                   

###### 

List of candidates for various deafness loci.

  Loci     Location     Candidates   Loci     Location          Candidates
  -------- ------------ ------------ -------- ----------------- ------------
  DFNA7    1q21--q23    ATP1B1       DFNB5    14q12             \*\*
                        F5           DFNB13   7q34--36          SLC37A3
                        MYOC         DFNB17   7q31              WNT2
                        SLC19A2      DFNB19   18p11             LAMA1
                        POU2F1       DFNB20   11q25--qter       KCNJ1
  DFNA16   2q24         \*                                      TECTA
  DFNA18   3q22         \*\*                                    SLC37A2
  DFNA21   6p21         \*           DFNB27   2q23--q31         ITGA6
  DFNA23   14q21--q22   \*\*                                    SP3
  DFNA25   12q21--24    HAL          DFNB28   22q13             KCNJ4
                        SLC25A3                                 MT
                        IGF1                                    SOX10
  DFNA27   4q12         HAT          DFNB32   1p13.3--22.1      COL11A1
                        KDR/VEGFR2                              DR1
  DFNA30   15q25--26    \*\*                                    F3
  DFNA31   6p21.3       TNF          DFNB33   9q34.3            TUBB2
                        POU5F1                                  SLC34A3
  DFNA34   1q44         \*\*         DFNB35   14q24.1--24.3     NUMB
  DFNA42   5q31.1       FGF1                                    FOS
                        GFRA3        DFNB38   6q26--q27         QK1
                        IK           DFNB39   7q11.22--q21.12   POR
                        PCDH1        DFNB40   22q               CRYBB2
                        DIAPH1                                  SLC25A1
                        POU4F3                                  TBX1
  DFNA47   9p21--22     \*\*                                    

\*The chromosomal regions for DFNA16 and DFNA21 code for 7 and 9 genes, respectively. However, none of these genes were listed in the mouse or human inner ear databases. The candidates as described in the text are based on their functional significance.

\*\*The chromosomal regions for DFNA18, DFNA23, DFNA30, DFNA34, DFNA47 and DFNB5 code for a substantial number of genes. A small fraction of these genes are listed in human and mouse inner ear databases as shown in Table 6. Furthermore, no hits were scored by the protein interaction approach. Therefore the genes scoring hits in the ear databases may be considered as candidates and prioritized based on their function. Some of these priority candidates are described in the text.

###### 

Summary of gene numbers from expression-library filtered analysis.

  Condition   Map Location      Interval   Number of Genes   Mouse Synteny/Chromo \#   Mouse Genes   Human Cochlear Genes   Mouse Inner ear Genes   Interacting Proteins   Shared Interactors
  ----------- ----------------- ---------- ----------------- ------------------------- ------------- ---------------------- ----------------------- ---------------------- --------------------
  DFNA7       1q21--q23         18.6 Mb    153               1                         161           18                     6                       15                     5
  DFNA16      2q24              2.6 Mb     7                 2                         16            0                      0                       0                      0
  DFNA18      3q22              12 Mb      116               6, 9                      111           18                     4                       9                      1
  DFNA21      6p21              3.5 Mb     9                 10                        48            0                      0                       0                      0
  DFNA23      14q21--q22        8 Mb       79                12                        60            7                      1                       4                      0
  DFNA25      12q21--24         14 Mb      108               10, 5                     102           17                     2                       11                     3
  DFNA27      4q12              15 Mb      71                5                         97            10                     3                       7                      2
  DFNA30      15q25--26         7 Mb       74                7                         58            6                      1                       2                      0
  DFNA31      6p21.3            7.5 Mb     304               13, 17                    385           13                     1                       8                      2
  DFNA34      1q44              5 Mb       88                1                         23            3                      0                       1                      0
  DFNA42      5q31              12 Mb      176               13, 18                    153           21                     5                       16                     6
  DFNA47      9p21--22          9 Mb       65                4                         79            6                      1                       3                      0
  DFNB5       14q12             5.5 Mb     18                12                        37            2                      0                       2                      0
  DFNB13      7q34--36          1.4 Mb     14                6                         15            1                      0                       2                      1
  DFNB17      7q31              6.5 Mb     26                6                         43            3                      1                       2                      1
  DFNB19      18p11             2.8 Mb     13                17                        11            1                      1                       1                      1
  DFNB20      11q25--qter       13.4 Mb    152               9                         263           14                     1                       6                      3
  DFNB27      2q23--q31         11 Mb      79                2                         95            14                     3                       3                      2
  DFNB28      22q13             6.5 Mb     146               15                        154           15                     5                       7                      3
  DFNB32      1p13.3--22.1      16 Mb      74                3, 5                      89            13                     3                       3                      3
  DFNB33      9q34.3            3 Mb       86                2                         54            3                      4                       2                      2
  DFNB35      14q24.1--24.3     8.2 Mb     116               12                        103           8                      4                       3                      2
  DFNB38      6q26--q27         3.4 Mb     5                 17                        3             1                      0                       1                      1
  DFNB39      7q11.22--q21.12   18 Mb      114               5                         108           10                     2                       2                      0
  DFNB40      22q11.21--12.1    9 Mb       285               5, 10, 16                 76            10                     4                       4                      3
                                                                                                                                                                           
  Total                                    2378                                        2344          214                    52                      114                    41

###### 

Summary of gene numbers from unfiltered analysis.

  Condition   Map Location      Interval   Number of Genes   Interacting Proteins
  ----------- ----------------- ---------- ----------------- ----------------------
  DFNA7       1q21--q23         18.6 Mb    153               29
  DFNA16      2q24              2.6 Mb     7                 1
  DFNA18      3q22              12 Mb      116               21
  DFNA21      6p21              3.5 Mb     9                 3
  DFNA23      14q21--q22        8 Mb       79                29
  DFNA25      12q21--24         14 Mb      108               33
  DFNA27      4q12              15 Mb      71                9
  DFNA30      15q25--26         7 Mb       74                18
  DFNA31      6p21.3            7.5 Mb     304               48
  DFNA34      1q44              5 Mb       88                19
  DFNA42      5q31              12 Mb      176               48
  DFNA47      9p21--22          9 Mb       65                19
  DFNB5       14q12             5.5 Mb     18                5
  DFNB13      7q34--36          1.4 Mb     14                6
  DFNB17      7q31              6.5 Mb     26                9
  DFNB19      18p11             2.8 Mb     13                3
  DFNB20      11q25--qter       13.4 Mb    152               24
  DFNB27      2q23--q31         11 Mb      79                12
  DFNB28      22q13             6.5 Mb     146               27
  DFNB32      1p13.3--22.1      16 Mb      74                11
  DFNB33      9q34.3            3 Mb       86                8
  DFNB35      14q24.1--24.3     8.2 Mb     116               19
  DFNB38      6q26--q27         3.4 Mb     5                 1
  DFNB39      7q11.22--q21.12   18 Mb      114               12
  DFNB40      22q11.21--12.1    9 Mb       285               25
                                                             
  Total                                    2378              439

###### 

Candidate genes from unfiltered HPRD analysis\*.

  -------- --------- -------- ---------
  DFNB13   RAB19B    DFNA7    CREG
  DFNB17   CAV2               DPT
           CAPZA2    DFNA18   PLXND1
           KCND2     DFNA21   E2F3
           ING3      DFNA23   DAAM1
  DFNB19   PTPRM              MNAT1
  DFNB20   GRIK4     DFNA25   HSyn
           NRGN               SELPLG
           RICS      DFNA27   SRP72
  DFNB27   MTX2               IGFBP7
           TTN                BRDG1
           NEUROD1            YT521
  DFNB28   RANGAP1   DFNA30   CIB1
  DFNB32   NTNG1              PRC1
  DFNB33   TRAF2     DFNA31   ABT1
           NPDC1              UBD
  DFNB35   PGF       DFNA34   SMYD3
           NGB                CIAS1
  DFNB39   UPK3B     DFNA42   NEUROG1
           PCLO               TTID
           GRM3               NRG2
  DFNB40   CLTCL1             PCDHAC1
           TXNRD2             PCDHAC2
           SDF2L1             NDFIP1
           MMP11     DFNA47   CDKN2A
           CABIN1             
  -------- --------- -------- ---------

\*The products of these genes shared interacting proteins with genes mapping to other deafness intervals. The above genes may be combined with the candidates predicted by the functional analysis and listed in Table 5.
